Page last updated: 2024-10-23

bisoprolol and Bleeding

bisoprolol has been researched along with Bleeding in 2 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Research Excerpts

ExcerptRelevanceReference
" Since telmisartan is an inhibitor of P-glycoprotein (P-gp), the elimination of rivaroxaban and apixaban, which are substrates of P-gp, is hindered, resulting in increased blood levels of both drugs, thereby increasing the risk of hemorrhage."4.02Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users. ( Akagi, Y; Aoyama, T; Enomoto, A; Hoshiko, M; Kawano, Y; Kujirai, A; Mano, Y; Nagata, M; Nakamatsu, S; Nakamura, S; Negishi, K; Nishikawa, T; Shimada, S; Suzuki, T; Tsukada, E, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Skalias, A1
Karamitsou, P1
Mitos, G1
Zarzava, E1
Tsapara, V1
Poutoglidis, A1
Gougousis, S1
Kawano, Y1
Nagata, M1
Nakamura, S1
Akagi, Y1
Suzuki, T1
Tsukada, E1
Hoshiko, M1
Kujirai, A1
Nakamatsu, S1
Nishikawa, T1
Enomoto, A1
Negishi, K1
Shimada, S1
Aoyama, T1
Mano, Y1

Trials

1 trial available for bisoprolol and Bleeding

ArticleYear
Does preoperative administration of hypotensive agents affect the quality of the surgical field during endoscopic sinus surgery? A triple-blind randomized controlled trial.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2023, Volume: 280, Issue:10

    Topics: Bisoprolol; Blood Loss, Surgical; Endoscopy; Hemorrhage; Humans; Nifedipine; Prospective Studies; Si

2023

Other Studies

1 other study available for bisoprolol and Bleeding

ArticleYear
Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users.
    Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:5

    Topics: Administration, Oral; Administrative Claims, Healthcare; Amlodipine; Anticoagulants; Antihypertensiv

2021